“Since the 2010s, several judgments of the Court of Cassation have considered that not offering fertility preservation when it can be envisaged amounted to moral damage and loss of opportunity if the lack of information and the harm to the patient has been established”
, explains Professor Éric Huyghe, urologist at the Toulouse University Hospital and co-responsible for the Expert Group (GEX) oncofertility of the French-speaking Association of Oncological Support Care (Afsos).
To discover
New rules for the health pass from January 15: all the answers to your questions
Read also
Cancer: cell therapy is progressing in Europe
But if patient information is supposed to be systematic, in reality, we are far from it!
“When there is an indication for fertility preservation, the information is not always given.
For example, in 2019, among children requiring an allogeneic blood stem cell transplant undergoing highly toxic treatments for the gonads, only 25% benefited from such a consultation.
The figures are a little better for women (around 40%), but this is still insufficient”
, confirms P Catherine…
This article is for subscribers only.
You have 92% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for 1€ the first month
I ENJOY IT
Already subscribed?
Login